Prelude Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
|
|||||
|
2025
Q1 | $2.07M | Sell |
|
|||||
|
2024
Q4 | $2.58M | Sell |
|
|||||
|
2024
Q3 | $3.73M | Sell |
|
|||||
|
2024
Q2 | $6.91M | Hold |
|
|||||
|
2024
Q1 | $5.93M | Buy |
|
|||||
|
2023
Q4 | $3.27M | Sell |
|
|||||
|
2023
Q3 | $3.43M | Sell |
|
|||||
|
2023
Q2 | $3.44M | Buy |
|
|||||
|
2023
Q1 | $996K | Sell |
|
|||||
|
2022
Q4 | $1.27M | Sell |
|
|||||
|
2022
Q3 | $1.17M | Sell |
|
|||||
|
2022
Q2 | $2.33M | Buy |
|
|||||
|
2022
Q1 | $735K | Sell |
|
|||||
|
2021
Q4 | $1.85M | Buy |
|
|||||
|
2021
Q3 | $832K | Sell |
|
|||||
|
2021
Q2 | $1.25M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $99K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $130K | Sell |
|
|||||
|
2019
Q4 | $1.52M | Buy |
|
|||||
|
2019
Q3 | – | Hold |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $61K | Sell |
|
|||||
|
2018
Q4 | $385K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $199K | Sell |
|
|||||
|
2017
Q1 | $2.84M | Buy |
|
|||||
|
2016
Q4 | $2.43M | Buy |
|
|||||
|
2016
Q3 | $1.89M | Buy |
|
|||||
|
2016
Q2 | $339K | Sell |
|
|||||
|
2016
Q1 | $367K | Buy |
|
|||||
|
2015
Q4 | $85K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $161K | Buy |
|
|||||
|
2014
Q4 | $32K | Sell |
|
|||||
|
2014
Q3 | $71K | Buy |
|
|||||
|
2014
Q2 | $48K | Sell |
|
|||||
|
2014
Q1 | $126K | Sell |
|
|||||
|
2013
Q4 | $149K | Sell |
|
|||||
|
2013
Q3 | $255K | Buy |
|
|||||
|
2013
Q2 | $152K | Buy |
|